Immunoassay News and Research

RSS

New immuno-assay can detect small molecules with 50-fold greater sensitivity

As medical science has come to understand that the human body is controlled on the molecular level by various proteins, hormones, drugs, and other substances, technologies have developed to detect levels of these molecules in order to monitor health and diagnose disease.

6 Dec 2018

Two Roche Diagnostic tests identified as transformative products for rapid uptake

Roche Diagnostics tests for suspected pre-eclampsia and heart attack have been recognized as ‘transformative’ and have been selected among only seven Rapid Uptake Products for the NHS.

From Roche Sequencing and Life Science 23 Oct 2018

Scientists develop urine diagnostic to detect parasitic worms that cause river blindness

Scientists at Scripps Research have developed a urine diagnostic to detect the parasitic worms that cause river blindness, also called onchocerciasis, a tropical disease that afflicts 18 to 120 million people worldwide.

28 Aug 2018

New Rekovelle analysis shows AMH is robust predictor of ovarian response to fertility treatment

Ferring Pharmaceuticals announced today a new analysis of data from the Phase 3 ESTHER-1 trial showing that natural variations in anti-Müllerian hormone levels during and between a woman's menstrual cycle have no clinically relevant impact on ovarian response when using AMH to dose Rekovelle for ovarian stimulation.

2 Jul 2018

InDevR releases first reagent kit for assessing neuraminidase in influenza vaccines

InDevR Inc. announced product release of the first ever commercial reagent kit designed explicitly for assessment of neuraminidase in influenza vaccines.

12 Jun 2018

$2 million funding boosts progress of UAB biomedical startup

A $2 million investment is the latest step forward for the biomedical startup CNine Biosolutions LLC, which is headed by former University of Alabama at Birmingham postdoctoral fellow Theresa Schein, Ph.D., and retired UAB microbiology professor Scott Barnum, Ph.D. This funding comes from a Denver angel investor group.

20 Apr 2018

AYOXXA to develop multiplex immunoassay to support treatment of sepsis patients

AYOXXA Biosystems GmbH, an international biotechnology company, will develop a multiplex assay to support the treatment of sepsis patients as part of the project "SepsisData.Net.NRW - Digitized Pattern Recognition for Personalized Treatment of Sepsis Patients". The development will be based on the Company’s innovative bead-based protein analysis platform LUNARIS™.

20 Apr 2018

AYOXXA introduces new LUNARIS Mouse 12-Plex Th17 Kit for quantitative analysis of Th17 cell biology

AYOXXA Biosystems GmbH, an international biotechnology company, focused on the development of innovative multiplex protein analysis technologies enabling translational research in basic and clinical research, today announced the expansion of its catalogue of immunoassays for multiplex protein analysis with the introduction of LUNARIS™ Mouse 12-Plex Th17 Kit for the quantitative analysis of soluble mouse T helper 17 (Th17) cell-related markers.

20 Apr 2018

FDA approves new tests to detect tickborne parasite in human plasma and whole blood samples

The U.S. Food and Drug Administration today approved the Imugen Babesia microti Arrayed Fluorescent Immunoassay, for the detection of antibodies to Babesia microti (B. microti) in human plasma samples, and the Imugen Babesia microti Nucleic Acid Test (NAT), for the detection of B. microti DNA in human whole blood samples.

7 Mar 2018

Report sheds light on global market for infectious disease immunoassays

Kalorama Information says that infectious disease immunoassays beat the IVD market and the overall IVD market in terms of revenue growth. Immunoassays are tests that are based on the binding of antibodies to antigens to identify the presence of a substance.

16 Oct 2017

World’s only Atomo HIV Self Test receives CE Marking from European Union Notified Body

Atomo Diagnostics, a world leader in innovative point-of-care, rapid diagnostic devices, announced today that its Atomo HIV Self Test has been granted CE Marking by a European Union Notified Body.

12 Oct 2017

Disease diagnostic tools win top honors in DEBUT challenge

Tools to diagnose Alzheimer's disease and latent tuberculosis are among the winning projects in the Design by Biomedical Undergraduate Teams (DEBUT) challenge, a biomedical engineering design prize competition for teams of undergraduate students.

26 Aug 2017

Quanterix announces launch of new SR-Plex benchtop instrument for high sensitivity biomarker analysis

Quanterix Corporation, a company dedicated to digitizing biomarker analysis with the goal of advancing the science of precision health, today announced it will be expanding its single molecule array, or Simoa, technology platform portfolio to include the new Quanterix SR-Plex benchtop instrument.

23 Aug 2017

Binding Site launches new antigens and antibodies for infectious/contagious diseases

The Immunologicals Group of The Binding Site is pleased to announce the launch of a number of new monoclonal antibodies and recombinant antigens focused on a variety of infectious/contagious disease states – including Cytomegalovirus (CMV), Hepatitis, HIV, Rubella, Syphilis, and Toxoplasmosis.

From Binding Site 29 Jul 2017

Ultra-sensitive C. difficile toxin assay may be critical tool for improving diagnosis of infectious disease

Findings presented at the American Society for Microbiology's ASM Microbe conference show that the ultra-sensitive Clostridium difficile toxin A/B assay in development for use on the Sgx Clarity™ system offers excellent sensitivity and may be a critical tool for improving the diagnosis of this life-threatening infection.

29 Jul 2017

Roche receives FDA clearance for new high-volume testing immunoassay solution

Roche announced today that its new, dedicated high-volume testing immunoassay solution for the cobas 8000 modular analyzer series, the cobas e 801 module, has received 510(k) clearance from the U.S. Food and Drug Administration.

27 Jul 2017

Alinity: the future of diagnostics?

Diagnostic tests are critical as up to 60 to 70% of critical clinical decisions are influenced by diagnostic test results. It's of huge importance to the running of any healthcare system. Here at Abbott, we believe that providing clinicians with quick access to diagnostics information and insights can help them make quick clinical decisions around the appropriate treatment for a patient,

From Abbott Diagnostics 14 Jun 2017

Study explores how to predict and prevent psychiatric morbidity in survivors of ARDS

After surviving acute respiratory distress syndrome, a disease in which fluid begins to leak into the lungs of critically ill patients and makes it difficult to breathe, many patients develop mental illness.

5 Apr 2017

Siemens Healthineers introduces new CE-marked immunoassay for detecting Zika virus

Siemens Healthineers announced today its CE-marked immunoassay—the NovagnostZika Virus IgM µ-capture Assay—is now commercially available to laboratories outside of the U.S.

24 Jan 2017

Siemens laboratory diagnostics department undergoes expansion

Siemens Healthineers will invest around $300 million in its Walpole, Mass. laboratory diagnostics manufacturing and research and development facility. The investment extends over four years and is another proof point that Siemens Healthineers invests in innovation to enable healthcare providers around the world to meet their current challenges and to excel in their respective environments.

15 Dec 2016

Immunoassay News and Research

New immuno-assay can detect small molecules with 50-fold greater sensitivity

Two Roche Diagnostic tests identified as transformative products for rapid uptake

Scientists develop urine diagnostic to detect parasitic worms that cause river blindness

New Rekovelle analysis shows AMH is robust predictor of ovarian response to fertility treatment

InDevR releases first reagent kit for assessing neuraminidase in influenza vaccines

$2 million funding boosts progress of UAB biomedical startup

AYOXXA to develop multiplex immunoassay to support treatment of sepsis patients

AYOXXA introduces new LUNARIS Mouse 12-Plex Th17 Kit for quantitative analysis of Th17 cell biology

FDA approves new tests to detect tickborne parasite in human plasma and whole blood samples

Report sheds light on global market for infectious disease immunoassays

World’s only Atomo HIV Self Test receives CE Marking from European Union Notified Body

Disease diagnostic tools win top honors in DEBUT challenge

Quanterix announces launch of new SR-Plex benchtop instrument for high sensitivity biomarker analysis

Binding Site launches new antigens and antibodies for infectious/contagious diseases

Ultra-sensitive C. difficile toxin assay may be critical tool for improving diagnosis of infectious disease

Roche receives FDA clearance for new high-volume testing immunoassay solution

Alinity: the future of diagnostics?

Study explores how to predict and prevent psychiatric morbidity in survivors of ARDS

Siemens Healthineers introduces new CE-marked immunoassay for detecting Zika virus

Siemens laboratory diagnostics department undergoes expansion

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News